MoneyWorks4Me

Hikal - Quaterly Results

28 May 2026 Evaluate
A decrease in the sales to Rs. 5194.00 millions was observed for the quarter ended March 2026. The sales stood at Rs. 5524.00 millions during the similar quarter previous year.Net Profit of the company move down -70.97% to Rs. 146.00  millions from Rs. 503.00 millions  in the same quarter last year.The company reported a degrowth in operating Profit to 1122.00 millions from 1240.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 5194.00 5524.00 -5.97 17126.00 18598.00 -7.91 17126.00 18598.00 -7.91
Other Income 66.00 5.00 1220.00 123.00 50.00 146.00 123.00 50.00 146.00
PBIDT 1122.00 1240.00 -9.52 2328.00 3335.00 -30.19 2328.00 3335.00 -30.19
Interest 146.00 179.00 -18.44 621.00 752.00 -17.42 621.00 752.00 -17.42
PBDT 505.00 1061.00 -52.40 856.00 2583.00 -66.86 856.00 2583.00 -66.86
Depreciation 420.00 377.00 11.41 1638.00 1344.00 21.88 1638.00 1344.00 21.88
PBT 85.00 684.00 -87.57 -782.00 1239.00 -163.12 -782.00 1239.00 -163.12
TAX -61.00 181.00 -133.70 -295.00 330.00 -189.39 -295.00 330.00 -189.39
Deferred Tax -41.00 8.00 -612.50 -275.00 30.00 -1016.67 -275.00 30.00 -1016.67
PAT 146.00 503.00 -70.97 -487.00 909.00 -153.58 -487.00 909.00 -153.58
Equity 247.00 247.00 0.00 247.00 247.00 0.00 247.00 247.00 0.00
PBIDTM(%) 21.60 22.45 -3.77 13.59 17.93 -24.19 13.59 17.93 -24.19
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..